The heterocycles ( 1 ) and ( 2 ) were obtained by oxidative addition of (η 5 -pentamethylcyclopentadienyl)gallium(I) (Cp*Ga) to Dipp-DAB (1,4 - bis(2,6-diisopropylphenyl)-1,4-diazabuta-1,3-diene) and Dep-DAB (1,4 - bis(2,6-diethylphenyl)-1,4-diazabuta-1,3-diene), respectively. Compounds 1 and 2 are the first examples of monomeric gallium-containing heterocycles of the diazabutadiene (DAB) type. 1 was structurally characterized by X-ray crystallography. In contrast, the reaction of Cp*Ga with Bu t -DAB (1,4-di- tert -butyl-1,4-diazabuta-1,3-diene) led to the formation of the known radical (Ga[Bu t -DAB] 2 ) ( 3 ) in high yield, thus providing an alternative synthesis to the cocondensation technique used previously. Radical 3 was further characterized by 1 H NMR spectroscopy and cyclic voltammetric studies, which revealed two reversible oxidation steps and one reversible reduction step.
No takes yet. Share an insight, caveat, or question.
Pott et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: